Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Corporate Video: AstraZeneca [LSE:AZN] CEO David Brennan Discusses Full-year Results.

|Includes: AstraZeneca Group plc (AZN)

AstraZeneca [LSE:AZN] CEO David Brennan discusses full-year results ¬

AstraZeneca, the Anglo-Swedish pharmaceutical company, says that government price intervention has reduced its revenues by about $1bn as it announced further restructuring alongside its full-year results. David Brennan, CEO, discusses AstraZeneca's portfolio performance and the prospects for the pipeline in light of recent disappointments.

3B NEXUS multimedia platform & portal for business, investors and market experts.